Skip to content
Log in
Sponsored Artificial Intelligence: A Modern Approach, Global Edition Artificial Intelligence: A Modern Approach, Global Edition

[Prediction and verification of therapeutic drugs for triple-negative breast cancer using a knowledge graph-based drug repurposing model].

Di Wu Zhan-Fa Xu Yi Li Mingxu Zhang Jia-Ze Lin Yi-Jun Lu D. Guan Geng-Geng Qin
Aug 2026 · Nan fang yi ke da xue xue bao = Journal of Southern Medical University · Vol 46 8, pp. 1947-1955 · 0 citations
Medicine

TL;DR

The KGNN model can effectively predict drug-target interactions to facilitate drug repurposing and the design of multi-target drugs while reducing the screening space and experimental validation costs.

DOI PubMed Semantic Scholar
View source

Similar papers

#graph neural networks Open access Sep 2026

Heterogeneous graph neural networks with biological prior knowledge for interpretable drug repurposing in triple-negative breast cancer

Paired Wilcoxon tests in 39 AURORA-US patients with matched primary and metastatic samples confirm that 4 of the 10 IG-identified TFs are significantly altered during metastatic progression after Bonferroni correction.

C. Fernandez-Lozano, David Ferreiro, Patricia V.-del-Río · 0 citations
Open access Aug 2026

Drug sensitivity prediction across cancer types using graph isomorphism networks and biological pathway features: A dual-branch deep learning approach

An innovative dual-branch approach based on Graph Isomorphism Network drug representations coupled with a Multilayer Perceptron (MLP) for 50-dimensional ssGSEA pathway activities calculated from CCLE gene expression is proposed, proving the importance of biological features in the two-branch model.

Shuang Li, Quan-Zhong Yang, Feifei Shen et al. · 0 citations
Aug 2026

IHLO-DTI: Drug-Target Interaction Prediction Based on Improved Hypergraph Neural Network and Laplacian Matrix Optimization

IHLO-DTI, a novel prediction model based on an improved hypergraph neural network and Laplacian matrix optimization, can effectively capture high-order many-to-many interactions between drugs and targets, improving prediction accuracy and robustness.

Guolongwei Dai, Tao Luo, Dan-Dan Li et al. · 0 citations
Aug 2026

CMAF-DDI: A Knowledge-Enhanced Cross-Modal Fusion Method Leveraging Protein Representation for Multi-Class Drug-Drug Interactions.

Experimental results show that CMAF-DDI improves multi-class DDI prediction compared with representative graph-based and multi-source fusion baselines and ablation, hyperparameter sensitivity, controlled protein perturbation, representation, and case-level analyses to examine the contribution and behavior of protein-en...

Heng-Peng Zhao, Xiaoli Lin, Jun Pang et al. · 1 citation
Open access Sep 2026

AI‑Driven Multi‑Omics Integrative Model for Predicting Tumor‑Specific Drug Responses

An AI-driven multi-omics model using GDSC, CCLE, DepMap, CTRP, and TCGA data, integrating mutation, copy-number variation, RNA expression, DNA methylation, drug SMILES, and IC50/AUC responses is developed, demonstrating that multi-omics fusion and drug-structure modeling improve prediction stability and support interpr...

Xin-Yuan Kang, Ai-Lin Deng · 0 citations
Aug 2026

A Knowledge Graph–Driven Multimodal Framework for Drug–Disease Association Prediction

KGDDA is proposed, a multimodal framework designed for drug-disease association prediction that synergistically integrates KGs with medical ontologies, enabling the adaptive capture of intricate drug-disease interactions.

Qi-Chang Zhao, Qiao Ling, Muhammad Habibulla Alamin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.